4.6 Article

Cutting Edge: Expression of the Transcription Factor E74-Like Factor 4 Is Regulated by the Mammalian Target of Rapamycin Pathway in CD8+ T Cells

Journal

JOURNAL OF IMMUNOLOGY
Volume 185, Issue 7, Pages 3824-3828

Publisher

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1000718

Keywords

-

Categories

Funding

  1. National Cancer Institute of the National Institutes of Health [KO1CA099156-01]
  2. Curtis Hankamer Basic Research Fund
  3. Dan Duncan Cancer Center at Baylor College of Medicine
  4. National Institute of Allergy and Infectious Diseases [1RO1AI077536-01]

Ask authors/readers for more resources

T cell receptor activation inhibits expression of the E74-like factor (ELF) 4 and Kru ppel-like factor 4 genes to release naive CD8(+) T cells from their quiescent state. In this study, we show that ELF4 controls the ERKmediated proliferative response by maintaining normal levels of dual-specificity phosphatases 1 and 5 in CD8(+) T cells. In activated CD8(+) T cells, the mammalian target of rapamycin pathway inhibits ELF4 and Kru ppel-like factor 4 expression downstream of ERK and PI3K signaling. Our findings demonstrate that rapamycin could be used to modulate expression of this transcriptional network involved in cell-cycle regulation. The Journal of Immunology, 2010, 185: 3824-3828.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available